3-(4-Chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine

HCID 4878CAS 172889-27-9

기본 정보

표준 SMILES
CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21
InChIKey
PBBRWFOVCUAONR-UHFFFAOYSA-N
분자식
C15H16ClN5
평균 분자량
301.77 g/mol
단동위원소 질량
301.1094232

이름 및 식별자

우선 이름
3-(4-Chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine
IUPAC
1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine
영어명
PP2
분자식
C15H16ClN5
분자량
301.77

이름 및 동의어

DTXSID602744473-(4-Chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1h-pyrazolo(3,4-d)pyrimidin-4-amine3-CDPPA cpdRefChem:888895DTXCID30225926172889-27-9pp21-(tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-aminePP 2Src kinase inhibitor PP21-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
이름 더 보기
CS-717AGL 1879PP2(AG 1879)PP2(AGL 1879)AG 1879,AGL 1879PP2, 10 mM in DMSOAGL 1879PP 2 (enzyme inhibitor)
AG 18791-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine4fewMFCD01568210PP-24-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine2zv9PP2 (enzyme inhibitor)

데이터베이스 식별자

CAS
172889-27-9
PubChem CID
4878
DTXSID
DTXSID60274447
ChEMBL
CHEMBL406845
ChEBI
CHEBI:78331
UNII
PK8JPC58XB
EC Number
878-892-3
Nikkaji
J704.782G

물성

구조 계산 물성

XLogP
3
극성 표면적
69.6 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
4
회전 가능 결합 수
2
무거운 원자 수
21

물리화학적 성질

끓는 점
493.5 · 493.5±40.0 °C(Predicted)
밀도
1.35 · 1.35±0.1 g/cm3(Predicted)
저장 조건
2 · 2-8°C
용해도
DMSO(최대 25mg/ml) 또는 에탄올(가온 시 최대 3mg/ml)에 용해됩니다.
물리적 상태
회백색 고체
산도 계수 (pKa)
3.96 · 3.96±0.30(Predicted)

안전 및 규제

GHS 분류

GHS Classification · 5건

Danger

H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral];H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (50%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H413 (50%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]

P264, P264+P265, P270, P273, P280, P301+P316, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 3 (50%);Skin Irrit. 2 (50%);Eye Irrit. 2 (50%);Aquatic Chronic 4 (50%)

안전 데이터

ridadr
UN 2811 6.1 / PGIII
risk_code
25
hazard_code
T
safety_code
45
Hazard Classifications
Acute Tox. 3 Oral
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

응용 분야 · 2건

개요The Src family of non-receptor tyrosine kinases regulate cell adhesion, growth, and differentiation through activation of multiple intracellular signaling pathways. Normally inactive, Src kinases are transiently activated during mitosis and constitutively activated by abnormal mutations. PP2 is a potent, reversible, ATP-competitive, and selective inhibitor of the Src family of protein tyrosine kinases. It inhibits p56lck (IC50 = 4 nM), p59fynT (IC50 = 5 nM), Hck (IC50 = 5 nM), and Src (IC50 = 100 nM). PP2 does not significantly affect the activity of EGFR kinase (IC50 = 480 nM), JAK2 (IC50 > 50 μM), or ZAP-70 (IC50 > 100 μM). PP2 inhibits the activation of focal adhesion kinase as well as its phosphorylation at Tyr577. PP2 also inhibits anti-CD3-stimulated tyrosine phosphorylation of human T-cells with an IC50 value of 600 nM.

용도PP2 has been used:to analyze the effects of Src/focal adhesion kinase (FAK) signaling on IQ domain GTPase-activating protein 1 (IQGAP1)-mediated anoikis resistancefor Src inhibition to study its effect on epidermal growth factor receptor (EGFR) and nuclear factor erythroid 2-related factor 2 (Nrf2) phosphorylation in non-small cell lung cancer (NSCLC) cellsfor pharmacological inhibition of SRC in MDA-MB-231 breast cancer cells

공급사50 곳

陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
南通飞宇生物科技有限公司0513-68819626 15152877458 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
成都彼样生物科技有限公司18108052721 · [email protected]

관련 반응

2건

연결된 노트

불러오는 중…